160 related articles for article (PubMed ID: 22009216)
1. Prostate-specific membrane antigen: a new potential prognostic marker of osteosarcoma.
Zeng C; Ke ZF; Yang Z; Wang Z; Yang SC; Luo CQ; Wang LT
Med Oncol; 2012 Sep; 29(3):2234-9. PubMed ID: 22009216
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.
Haffner MC; Kronberger IE; Ross JS; Sheehan CE; Zitt M; Mühlmann G; Ofner D; Zelger B; Ensinger C; Yang XJ; Geley S; Margreiter R; Bander NH
Hum Pathol; 2009 Dec; 40(12):1754-61. PubMed ID: 19716160
[TBL] [Abstract][Full Text] [Related]
3. Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma.
Jiao D; Li Y; Yang F; Han D; Wu J; Shi S; Tian F; Guo Z; Xi W; Li G; Zhao A; Yang AG; Qin W; Wang H; Wen W
Clin Transl Gastroenterol; 2019 May; 10(5):1-7. PubMed ID: 31116141
[TBL] [Abstract][Full Text] [Related]
4. Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms.
Baccala A; Sercia L; Li J; Heston W; Zhou M
Urology; 2007 Aug; 70(2):385-90. PubMed ID: 17826525
[TBL] [Abstract][Full Text] [Related]
5. Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.
Moore M; Panjwani S; Mathew R; Crowley M; Liu YF; Aronova A; Finnerty B; Zarnegar R; Fahey TJ; Scognamiglio T
Endocr Pathol; 2017 Dec; 28(4):339-344. PubMed ID: 28844117
[TBL] [Abstract][Full Text] [Related]
6. The expression of novel gene URG4 in osteosarcoma: correlation with patients' prognosis.
Huang J; Zhu B; Lu L; Lian Z; Wang Y; Yang X; Satiroglu-Tufan NL; Liu J; Luo Z
Pathology; 2009 Feb; 41(2):149-54. PubMed ID: 18972316
[TBL] [Abstract][Full Text] [Related]
7. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.
Ananias HJ; van den Heuvel MC; Helfrich W; de Jong IJ
Prostate; 2009 Jul; 69(10):1101-8. PubMed ID: 19343734
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.
Kasoha M; Unger C; Solomayer EF; Bohle RM; Zaharia C; Khreich F; Wagenpfeil S; Juhasz-Böss I
Clin Exp Metastasis; 2017 Dec; 34(8):479-490. PubMed ID: 29426963
[TBL] [Abstract][Full Text] [Related]
9. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
10. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
[TBL] [Abstract][Full Text] [Related]
11. Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.
Samplaski MK; Heston W; Elson P; Magi-Galluzzi C; Hansel DE
Mod Pathol; 2011 Nov; 24(11):1521-9. PubMed ID: 21725290
[TBL] [Abstract][Full Text] [Related]
12. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.
Ross JS; Sheehan CE; Fisher HA; Kaufman RP; Kaur P; Gray K; Webb I; Gray GS; Mosher R; Kallakury BV
Clin Cancer Res; 2003 Dec; 9(17):6357-62. PubMed ID: 14695135
[TBL] [Abstract][Full Text] [Related]
13. PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma.
Wang W; Tavora F; Sharma R; Eisenberger M; Netto GJ
Urol Oncol; 2009; 27(5):525-8. PubMed ID: 18534872
[TBL] [Abstract][Full Text] [Related]
14. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma.
Feng H; Guo P; Wang J; Xu J; Xie C; Gao F
Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024
[TBL] [Abstract][Full Text] [Related]
15. Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study.
Rastogi S; Kumar R; Sankineani SR; Marimuthu K; Rijal L; Prakash S; Jalan D; Khan SA; Sharma MC
Int Orthop; 2012 Nov; 36(11):2315-21. PubMed ID: 23015149
[TBL] [Abstract][Full Text] [Related]
16. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
Kubo T; Shimose S; Fujimori J; Furuta T; Arihiro K; Ochi M
Clin Orthop Relat Res; 2015 Jan; 473(1):305-10. PubMed ID: 25193692
[TBL] [Abstract][Full Text] [Related]
17. Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma.
Crowley MJ; Scognamiglio T; Liu YF; Kleiman DA; Beninato T; Aronova A; Liu H; Jhanwar YS; Molina A; Tagawa ST; Bander NH; Zarnegar R; Elemento O; Fahey TJ
J Clin Endocrinol Metab; 2016 Mar; 101(3):981-7. PubMed ID: 26771706
[TBL] [Abstract][Full Text] [Related]
18. High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.
Haffner MC; Laimer J; Chaux A; Schäfer G; Obrist P; Brunner A; Kronberger IE; Laimer K; Gurel B; Koller JB; Seifarth C; Zelger B; Klocker H; Rasse M; Doppler W; Bander NH
Mod Pathol; 2012 Aug; 25(8):1079-85. PubMed ID: 22460809
[TBL] [Abstract][Full Text] [Related]
19. Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with
Matsuda M; Ishikawa E; Yamamoto T; Hatano K; Joraku A; Iizumi Y; Masuda Y; Nishiyama H; Matsumura A
J Neurooncol; 2018 Jul; 138(3):581-589. PubMed ID: 29524126
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma.
Nada OH; Ahmed NS; Abou Gabal HH
Diagn Pathol; 2014 Mar; 9():72. PubMed ID: 24667142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
